BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bley N, Schott A, Müller S, Misiak D, Lederer M, Fuchs T, Aßmann C, Glaß M, Ihling C, Sinz A, Pazaitis N, Wickenhauser C, Vetter M, Ungurs O, Strauss HG, Thomssen C, Hüttelmaier S. IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer. RNA Biol 2021;18:391-403. [PMID: 32876513 DOI: 10.1080/15476286.2020.1812894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou L, Li J, Liu J, Wang A, Liu Y, Yu H, Ouyang H, Pang D. Investigation of the lncRNA THOR in Mice Highlights the Importance of Noncoding RNAs in Mammalian Male Reproduction. Biomedicines 2021;9:859. [PMID: 34440063 DOI: 10.3390/biomedicines9080859] [Reference Citation Analysis]
2 Li X, Feng Z, Wang R, Hu J, He X, Shen Z. Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung Adenocarcinoma. Life (Basel) 2021;11:619. [PMID: 34206803 DOI: 10.3390/life11070619] [Reference Citation Analysis]
3 Glaß M, Misiak D, Bley N, Müller S, Hagemann S, Busch B, Rausch A, Hüttelmaier S. IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer. Front Mol Biosci 2021;8:632219. [PMID: 33829040 DOI: 10.3389/fmolb.2021.632219] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Du QY, Zhu ZM, Pei DS. The biological function of IGF2BPs and their role in tumorigenesis. Invest New Drugs 2021. [PMID: 34251559 DOI: 10.1007/s10637-021-01148-9] [Reference Citation Analysis]
5 Misiak D, Hagemann S, Bell JL, Busch B, Lederer M, Bley N, Schulte JH, Hüttelmaier S. The MicroRNA Landscape of MYCN-Amplified Neuroblastoma. Front Oncol 2021;11:647737. [PMID: 34026620 DOI: 10.3389/fonc.2021.647737] [Reference Citation Analysis]
6 Li Q, Ren CC, Chen YN, Yang L, Zhang F, Wang BJ, Zhu YH, Li FY, Yang J, Zhang ZA. A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer. Front Cell Dev Biol 2021;9:703969. [PMID: 34631700 DOI: 10.3389/fcell.2021.703969] [Reference Citation Analysis]